Boston Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1.67M Sell
11,588
-11,338
-49% -$1.65M 0.09% 286
2019
Q2
$3.4M Sell
22,926
-4,163
-15% -$581K 0.18% 154
2019
Q1
$3.56M Sell
27,089
-803
-3% -$98.9K 0.18% 155
2018
Q4
$3.03M Sell
27,892
-483
-2% -$64.7K 0.18% 156
2018
Q3
$4.23M Sell
28,375
-1,869
-6% -$284K 0.18% 188
2018
Q2
$4.67M Buy
30,244
+1,146
+4% +$173K 0.12% 188
2018
Q1
$4.04M Buy
29,098
+873
+3% +$128K 0.1% 208
2017
Q4
$3.87M Buy
28,225
+11
+0% +$1.45K 0.08% 243
2017
Q3
$3.66M Sell
28,214
-2,404
-8% -$321K 0.08% 245
2017
Q2
$4.05M Sell
30,618
-92,759
-75% -$11.4M 0.09% 238
2017
Q1
$15.2M Sell
123,377
-966
-0.8% -$114K 0.36% 93
2016
Q4
$13.7M Buy
124,343
+17,151
+16% +$1.91M 0.33% 92
2016
Q3
$12.7M Buy
107,192
+6,045
+6% +$712K 0.31% 100
2016
Q2
$11.3M Buy
101,147
+84,070
+492% +$9.05M 0.28% 117
2016
Q1
$1.72M Buy
17,077
+327
+2% +$31.4K 0.04% 269
2015
Q4
$1.78M Buy
16,750
+4,324
+35% +$446K 0.04% 273
2015
Q3
$1.16M Hold
12,426
0.04% 355
2015
Q2
$1.29M Buy
12,426
+139
+1% +$14.5K 0.05% 260
2015
Q1
$1.33M Sell
12,287
-1,759
-13% -$181K 0.05% 254
2014
Q4
$1.3M Buy
14,046
+198
+1% +$17.5K 0.05% 238
2014
Q3
$1.21M Hold
13,848
0.05% 258
2014
Q2
$1.22M Sell
13,848
-262
-2% -$22.7K 0.05% 258
2014
Q1
$1.19M Sell
14,110
-1,193
-8% -$95.1K 0.05% 258
2013
Q4
$1.2M Sell
15,303
-1,106
-7% -$94.3K 0.06% 252
2013
Q3
$1.4M Sell
16,409
-58
-0.4% -$4.88K 0.07% 217
2013
Q2
$1.42M Buy
+16,467
New +$1.37M 0.07% 212

Other funds holding LH

Boston Advisors's LH Position: Q3 2019 in Review

Boston Advisors reduced its Labcorp (LH) stake by 49% in Q3 2019, selling an estimated $1.65M and leaving 11,588 shares worth $1.67M. The position accounts for 0.09% of the portfolio, ranked #286.

Boston Advisors first reported a position in LH in Q2 2013 and has held it in 26 quarters since. The position peaked at $15.2M in Q1 2017. 738 funds tracked by Wall St. Rank hold LH as of Q3 2019.

  • Boston Advisors held 11,588 shares of Labcorp worth $1.67M as of Q3 2019.
  • Boston Advisors sold 11,338 Labcorp shares in Q3 2019, an estimated $1.65M.
  • Labcorp made up 0.09% of Boston Advisors's portfolio in Q3 2019, its #286 holding.
  • Boston Advisors first reported a position in Labcorp in Q2 2013 and has held it in 26 quarters since.
  • Boston Advisors's Labcorp position peaked at $15.2M in Q1 2017.
  • 738 funds tracked by Wall St. Rank held Labcorp as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.